Inventor · disambiguated record
Kathryn Hastie
Also filed as: HASTIE KATHRYN · HASTIE KATHRYN M
2 granted patents·8 pending applications·0 citations·filing 2017–2023
30Inventor score
Top patents by PatentIndex Score
10 records- 0181US12358971B2Arena virus monoclonal antibodies and usesTHE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND·Filed 2023·Granted Jul 15, 2025·0 cites·20 claims
- 0265US2022089696A1Arenavirus monoclonal antibodies and usesTHE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND·Filed 2021·Application pending·0 cites
- 0355US11198723B2Arenavirus monoclonal antibodies and usesTHE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND·Filed 2017·Granted Dec 14, 2021·0 cites·13 claims
- 0447US2024425550A1Engineered rabies virus glycoprotein, compositions, and methods of use thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 0546US2025382353A1Anti-sars-cov2 spike (s) antibodies and uses thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2023·Application pending·0 cites
- 0642US2025320278A1Chimeric anti-sars-cov2 nucleoprotein antibodiesLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 0742US2023310568A1Engineered arenavirus glycoprotein compositions and methods of use thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 0841US2024301037A1Chimeric anti-coronavirus spike protein antibodiesLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 0941US2025034213A1Engineered arenavirus glycoprotein compositions, methods and use thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 1040US2023391855A1Chimeric anti-sars-cov2 nucleoprotein antibodiesLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →